CliffBio
small molecule

PATADAY TWICE DAILY RELIEF

OLOPATADINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand namePATADAY TWICE DAILY RELIEF
Active ingredientOLOPATADINE HYDROCHLORIDE
StrengthEQ 0.1% BASE
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalDecember 1996
Marketing statusOTC

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PATADAY TWICE DAILY RELIEF patent cliff — loss of exclusivity — | CliffBio